Literature DB >> 15891662

Delivery of neurotrophin-3 to the cochlea using alginate beads.

Farnoosh Noushi1, Rachael T Richardson, Jennifer Hardman, Graeme Clark, Stephen O'Leary.   

Abstract

OBJECTIVE: The aim of this study was to design a novel cochlear neurotrophin (NT) delivery system for the rescue of auditory neurons after ototoxicity-induced deafening.
BACKGROUND: NT-3 is a trophic growth factor that promotes the survival of the auditory nerve and may have a potential therapeutic role in slowing neuron loss in progressive deafness, especially as an adjunct to the current cochlear implant. Beads made from alginate are biodegradable, slow release substances that can be placed at the round window or inside the cochlea. This study investigated the loading properties, release kinetics, and implantation potential of alginate beads loaded with NT-3.
METHODS: Alginate beads were prepared using an ionic gelation technique and postloaded with NT-3. Release of NT-3 was measured using enzyme-linked immunosorbent assay over 5 days. Alginate beads were implanted into deafened guinea pigs for 28 days, after which survival of auditory neurons was assessed.
RESULTS: Enzyme-linked immunosorbent assay studies demonstrated a 98% to 99% loading of NT-3 with a slow, partial release over 5 days in Ringer's solution. Furthermore, the addition of heparin to the delivery system modulated NT-3 release to a steadier pattern. Implantation of alginate-heparin beads in guinea pig cochleae produced minimal local tissue reaction. NT-3 loaded beads implanted at both the round window and within the scala tympani of the basal turn provided auditory neurons significant protection from degradation and apoptosis compared with unloaded beads or untreated cochleae.
CONCLUSIONS: This study demonstrates alginate beads to be a safe, biodegradable and effective delivery system for NT-3 to the cochlea.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891662     DOI: 10.1097/01.mao.0000169780.84588.a5

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  24 in total

Review 1.  Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system.

Authors:  Lisa N Pettingill; Rachael T Richardson; Andrew K Wise; Stephen J O'Leary; Robert K Shepherd
Journal:  IEEE Trans Biomed Eng       Date:  2007-06       Impact factor: 4.538

Review 2.  Current status and prospects of gene therapy for the inner ear.

Authors:  Hong Sun; Aji Huang; Shousong Cao
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

3.  A novel chitosan-hydrogel-based nanoparticle delivery system for local inner ear application.

Authors:  Shayanne A Lajud; Danish A Nagda; Peter Qiao; Nobuaki Tanaka; Alyssa Civantos; Rende Gu; Zhiliang Cheng; Andrew Tsourkas; Bert W O'Malley; Daqing Li
Journal:  Otol Neurotol       Date:  2015-02       Impact factor: 2.311

4.  The use of a dual PEDOT and RGD-functionalized alginate hydrogel coating to provide sustained drug delivery and improved cochlear implant function.

Authors:  Jennifer A Chikar; Jeffrey L Hendricks; Sarah M Richardson-Burns; Yehoash Raphael; Bryan E Pfingst; David C Martin
Journal:  Biomaterials       Date:  2011-12-17       Impact factor: 12.479

5.  Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels.

Authors:  Oju Jeon; Caitlin Powell; Loran D Solorio; Melissa D Krebs; Eben Alsberg
Journal:  J Control Release       Date:  2011-07-02       Impact factor: 9.776

6.  Brain-derived neurotrophic factor modulates auditory function in the hearing cochlea.

Authors:  David J Sly; Amy J Hampson; Ricki L Minter; Leon F Heffer; Jack Li; Rodney E Millard; Leon Winata; Allen Niasari; Stephen J O'Leary
Journal:  J Assoc Res Otolaryngol       Date:  2011-11-16

7.  Entry of substances into perilymph through the bone of the otic capsule after intratympanic applications in guinea pigs: implications for local drug delivery in humans.

Authors:  Anthony A Mikulec; Stefan K Plontke; Jared J Hartsock; Alec N Salt
Journal:  Otol Neurotol       Date:  2009-02       Impact factor: 2.311

Review 8.  The use of neurotrophin therapy in the inner ear to augment cochlear implantation outcomes.

Authors:  Cameron L Budenz; Bryan E Pfingst; Yehoash Raphael
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

9.  Localized cell and drug delivery for auditory prostheses.

Authors:  Jeffrey L Hendricks; Jennifer A Chikar; Mark A Crumling; Yehoash Raphael; David C Martin
Journal:  Hear Res       Date:  2008-06-07       Impact factor: 3.208

Review 10.  Inner ear drug delivery for auditory applications.

Authors:  Erin E Leary Swan; Mark J Mescher; William F Sewell; Sarah L Tao; Jeffrey T Borenstein
Journal:  Adv Drug Deliv Rev       Date:  2008-09-21       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.